Strata Critical Medical (SRTA) Return on Equity (2020 - 2025)
Strata Critical Medical (SRTA) has disclosed Return on Equity for 6 consecutive years, with 0.2% as the latest value for Q4 2025.
- Quarterly Return on Equity rose 26.0% to 0.2% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.2% through Dec 2025, up 26.0% year-over-year, with the annual reading at 0.25% for FY2025, 29.0% up from the prior year.
- Return on Equity for Q4 2025 was 0.2% at Strata Critical Medical, down from 0.23% in the prior quarter.
- The five-year high for Return on Equity was 0.23% in Q3 2025, with the low at 0.23% in Q4 2023.
- Average Return on Equity over 5 years is 0.08%, with a median of 0.08% recorded in 2022.
- The sharpest move saw Return on Equity tumbled -105bps in 2021, then surged 43bps in 2025.
- Over 5 years, Return on Equity stood at 0.06% in 2021, then tumbled by -65bps to 0.1% in 2022, then crashed by -131bps to 0.23% in 2023, then soared by 72bps to 0.06% in 2024, then soared by 421bps to 0.2% in 2025.
- According to Business Quant data, Return on Equity over the past three periods came in at 0.2%, 0.23%, and 0.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.